Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with 213Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic Tumors.
Saved in:
| Title: | Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with 213Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic Tumors. |
|---|---|
| Authors: | Helisch, Andreas1 (AUTHOR), Kratochwil, Clemens2,3 (AUTHOR), Kleist, Christian2 (AUTHOR), Krämer, Susanne2 (AUTHOR), Rosales Castillo, Juan Jose4 (AUTHOR), Dendl, Katharina2 (AUTHOR), Rathke, Hendrik2,5 (AUTHOR), von Goetze, Isabelle1 (AUTHOR), Schreckenberger, Mathias1 (AUTHOR), Jäger, Dirk6 (AUTHOR), Lindner, Thomas2,7 (AUTHOR), Mier, Walter2 (AUTHOR), Giesel, Frederik2,8 (AUTHOR), Haberkorn, Uwe2,3,9 (AUTHOR), Röhrich, Manuel1,2,3 (AUTHOR) manuel.roehrich@unimedizin-mainz.de |
| Source: | Journal of Nuclear Medicine. Dc2024, Vol. 65 Issue 12, p1917-1922. 6p. |
| Database: | Engineering Source |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 01615505 |
|---|---|
| DOI: | 10.2967/jnumed.124.268386 |
